24 /100
LOW RISK
Score updated May 29, 2026

CTMX — CytomX Therapeutics, Inc. Dilution Risk Tracker

Track CTMX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CTMX — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CTMX.
🔔 Track CTMX — Get forecast alerts →

💹 Market Data

Market Cap$807.68M
Shares Outstanding217.70M
Float186.26M
Cash$346.71M
Debt$2.86M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 8.0% shares (2025Q4 vs prior)
122 institutional holders · 150.79M shares
#1 FMR LLC 24.69M shares
#2 VR ADVISER, LLC 15.56M shares
#3 PERCEPTIVE ADVISORS LLC 9.68M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest29.74M
Days to Cover8.4
% of Float16.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track CTMX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CTMX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for CTMX
📊 CTMX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CTMX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.